✦ LIBER ✦

PND29 COST-UTILITY ANALYSIS OF RIZATRIPTAN VERSUS (GENERIC) SUMATRIPTAN IN SWEDEN

✍ Scribed by J Lundberg; WM Golden; RP Insinga

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PNL5 COST-EFFECTIVENESS ANALYSIS OF RIZA

✍ L Zhang; JW Hay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

PND27 COST UTILITY ANALYSIS OF ORPHAN DR

✍ M Willis; B Gradl 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

PGI9 COST-EFFECTIVENESS OF ESOMEPRAZOLE

✍ P Wahlqvist; H Sörngård 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PIN33 COST-UTILITY ANALYSIS OF RALTEGRAV

✍ M. Chaudhary; E.H. Elbasha; R.N. Kumar; J. Lundberg 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCN72 COST-UTILITY ANALYSIS OF GEFITINIB

✍ P Anaya; RJ López; AC Polanco 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

PDB60 A Cost-Utility Analysis of Pregaba

✍ B.K. Bellows; A. Dahal; T. Jiao; J. Biskupiak 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB